PECAM1 and Miyoshi myopathy: However, the percentage of samples with moderate/strong CD31 expression gradually decreased from cPC deriving from classical MM, MM-EMD and pEMP/SOP (and from classical MM to SOP or extramedullary manifestations paraskeletal vs. not paraskeletal).